Results 261 to 270 of about 90,478 (344)

Weight‐Reduction and Safety Profile of Once‐Weekly Non‐Comparable Biotherapeutic Subcutaneous Semaglutide Among People With Obesity: A Real‐World Retrospective Study

Health Science Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Background and Aims Semaglutide, a once‐weekly injectable glucagon‐like peptide, showed double‐digit weight reduction with an acceptable safety profile in clinical trials and real‐world studies. The efficacy and safety of non‐comparable biotherapeutic (NCB) semaglutide are not adequately reported. Our study aimed to assess the weight reduction
Md Rakibul Hasan, Kishore Kumar Shil, Md Shahed‐Morshed   +2 more
wiley   +1 more source

TWO CASES OF XANTHOGRANULOMATOUS CHOLECYSTITIS THAT WERE DIFFICULT TO TREAT WITH THE CORRECT SURGICAL PROCEDURE DUE TO THE POSSIBILITY OF GALLBLADDER CANCER

, 2010
Tatsuya Kinjo, Hiroki Sunagawa, Tetsuo Toyama, Susumu Inamine, Hisamitsu Zaha, Naoto Oshiro   +5 more
openalex   +2 more sources

Liver Cirrhosis Caused by Food‐Borne Zoonotic Fasciola gigantica in Cattle in Bangladesh: Pathology and Immunological Orchestra

Immunity, Inflammation and Disease, Volume 14, Issue 1, January 2026.
ABSTRACT Background Fasciolosis is a food‐borne parasitic zoonotic disease caused by widespread liver flukes that affect ruminants and humans, and is responsible for non‐resolving hepatic damage. Although fasciolosis occurs in both acute and chronic forms, chronic fasciolosis is more common.
Md. Haydar Ali, Joydeep Paul, Romana Parvin, Md. Shahadat Hossain, Sharmin Shahid Labony, Nusrat Nowrin Shohana, Md. Mahmudul Alam, Umme Razia Islam, Anita Rani Dey, Md. Abu Hadi Noor Ali Khan, Md. Abdul Alim, Anisuzzaman   +11 more
wiley   +1 more source

Comparative prognostic value of preoperative SII, NLR, and MLR and their association with TNM staging in gallbladder cancer: A multicenter retrospective study. [PDF]

Transl Oncol
Huang Z, Luo J, He J, Hu Q, Liao R, Xu J, Guo P, Liu Z, You N, Zhou B, Tao R.   +10 more
europepmc   +1 more source

Mastering Organoid Growth: A Complete Guide to Overcoming Methodological Challenges

MedComm, Volume 7, Issue 1, January 2026.
Organoids offer transformative 3D models that precisely mimic human organ architecture and function. This review details the latest methodology, emphasizing the cultivation of liver and other abdominal organoids. We analyze technological challenges (e.g., nutrient delivery, scalability, diversity) and provide practical insights for new researchers ...
Chunbao Jiao, Omer Faruk Karakaya, Neda Dadgar, Chase J. Wehrle, Zahra Massoud, Hanna Hong, Robert L. Fairchild, Nic Leipzig, Federico Aucejo, Wen Wee Ma, Jan Joseph Melenhorst, Sofia Ferreira Gonzales, Andrea Schlegel   +12 more
wiley   +1 more source

Development and challenges in the treatment of advanced gallbladder cancer (Review). [PDF]

Oncol Lett
Zhou B, Zhang SR, Chen G.
europepmc   +1 more source

Organoids in Cancer Research and Regenerative Medicine: Current Status, Challenges, and Future Prospects

MedComm, Volume 7, Issue 1, January 2026.
The management of cancer and tissue regeneration remains a substantial challenge to global health. Organoids, which are stem cell‐derived three‐dimensional multicellular structures, are revolutionizing biomedical research. Therefore, this review highlights their applications in cancer research and regenerative medicine, while discussing current ...
Ruiyang Li, Yuezhou Wu, Zhu'anzhen Zheng, Fengjin Zhou, Ke Xu, Jiacan Su   +5 more
wiley   +1 more source

Transplantation of the liver in human subjects [PDF]

, 1974
Putnam, CW, Starzl, TE
core  

Beyond PD‐1/PD‐L1: New Immune Checkpoints and Therapeutic Combinations in Cancer Immunotherapy

Medicine Bulletin, Volume 2, Issue 1, Page 61-93, January 2026.
ABSTRACT Recently, immune checkpoint inhibitors (ICIs), particularly PD‐1/PD‐L1 and CTLA‐4 inhibitors, have revolutionized cancer treatment, significantly improving survival rates for various malignancies. However, ICI therapies targeting single checkpoints on T cells still face numerous challenges, such as low response rates and post‐treatment ...
Yangyang Li, Zizhen Kang, Yanyun Du
wiley   +1 more source

Identification of novel therapeutic targets and effective anticancer agents for gallbladder cancer by integrating bioinformatics analysis and experimental validation. [PDF]

Front Pharmacol
Zhong Y, Zou R, Luo X, Yang S, He Z, Hu H, Li F.   +6 more
europepmc   +1 more source